Although augmented prostaglandin E 2 (PGE 2 ) accumulation has been demonstrated at the lesion sites of rodent ischemia models, the role of postischemic PGE 2 in neuronal survival has remained obscure. We recently identiˆed the microsomal prostaglandin E synthase-1 (mPGES-1), an inducible terminal enzyme for prostaglandin E 2 synthesis, as a critical factor in stroke-reperfusion injury. Co-induction of mPGES-1 and cyclooxygenase (COX)-2, an upstream enzyme for PGE 2 production, was observed after brain ischemia. In mPGES-1 knockout (KO) mice, in which the postischemic PGE 2 production in the cortex was completely absent, the ischemic injuries were less severe compared to those in wild-type (WT) mice. The ameliorated symptoms observed in KO mice after ischemia were reversed to almost the same severity as in the WT mice by intracerebroventricular injection of PGE 2 into KO mice. The induction of mPGES-1 was also observed after glutamate exposure in cultured hippocampal slices. In mPGES-1 KO slices, glutamate-induced excitotoxicity was less severe compared to that in WT slices. Among the EP1 4 antagonists and agonists, only the EP3 antagonist attenuated and only the EP3 agonist augmented the glutamate-induced excitotoxicity. Furthermore, intraperitoneal injection of COX-2 inhibitor or EP3 antagonist reduced the ischemic injuries in WT mice, but not in mPGES-1 KO mice. In EP3 KO mice, the ischemic injuries were less severe compared to those in WT mice. These results suggest that mPGES-1 and COX-2 are co-induced by excessive glutamate in the ischemic brain and act together to exacerbate stroke injury through PGE 2 production followed by activation of EP3 receptors.
Arachidonic acid, which is liberated from membrane phospholipids through phospholipase A 2 (PLA 2 ), is metabolized by cyclooxygenase (COX: COX-1 is the stable form and COX-2 is the inducible form) to the unstable endoperoxide PGH2, and then metabolized by prostaglandin E synthase (PGES: cPGES and mPGES-2 are the stable forms and mPGES-1 is the inducible form) to PGE 2 . PGH 2 is also metabolized to PGD 2 , PGI 2 and TXA 2 by PGDS, PGIS and TXS, respectively. PGE 2 acts on four G-proteincoupled receptors (EP1 EP4) that have very distinct and potentially antagonistic signaling cascades. 
